Literature DB >> 16484497

Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number.

Steven W Flavell1, Christopher W Cowan, Tae-Kyung Kim, Paul L Greer, Yingxi Lin, Suzanne Paradis, Eric C Griffith, Linda S Hu, Chinfei Chen, Michael E Greenberg.   

Abstract

In the mammalian nervous system, neuronal activity regulates the strength and number of synapses formed. The genetic program that coordinates this process is poorly understood. We show that myocyte enhancer factor 2 (MEF2) transcription factors suppressed excitatory synapse number in a neuronal activity- and calcineurin-dependent manner as hippocampal neurons formed synapses. In response to increased neuronal activity, calcium influx into neurons induced the activation of the calcium/calmodulin-regulated phosphatase calcineurin, which dephosphorylated and activated MEF2. When activated, MEF2 promoted the transcription of a set of genes, including arc and synGAP, that restrict synapse number. These findings define an activity-dependent transcriptional program that may control synapse number during development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484497     DOI: 10.1126/science.1122511

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  293 in total

1.  Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.

Authors:  Erwin H van den Burg; Benjamin Jurek; Inga D Neumann; Julia Winter; Magdalena Meyer; Ilona Berger; Melanie Royer; Marta Bianchi; Kerstin Kuffner; Sebastian Peters; Simone Stang; Dominik Langgartner; Finn Hartmann; Anna K Schmidtner; Stefan O Reber; Oliver J Bosch; Anna Bludau; David A Slattery
Journal:  Mol Psychiatry       Date:  2021-05-25       Impact factor: 15.992

2.  Cc2d1a, a C2 domain containing protein linked to nonsyndromic mental retardation, controls functional maturation of central synapses.

Authors:  Meng Zhao; Jesica Raingo; Zhijian James Chen; Ege T Kavalali
Journal:  J Neurophysiol       Date:  2011-01-27       Impact factor: 2.714

Review 3.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

4.  Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.

Authors:  Jayms D Peterson; Joshua A Goldberg; D James Surmeier
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

5.  Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

Authors:  Yaping Chu; Gerardo A Morfini; Lori B Langhamer; Yinzhen He; Scott T Brady; Jeffrey H Kordower
Journal:  Brain       Date:  2012-06-19       Impact factor: 13.501

6.  Regulation of brain-derived neurotrophic factor expression in neurons.

Authors:  Fei Zheng; Xianju Zhou; Changjong Moon; Hongbing Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 7.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

Review 8.  Human brain evolution: transcripts, metabolites and their regulators.

Authors:  Mehmet Somel; Xiling Liu; Philipp Khaitovich
Journal:  Nat Rev Neurosci       Date:  2013-01-17       Impact factor: 34.870

Review 9.  The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease.

Authors:  Irina Epstein; Steven Finkbeiner
Journal:  Semin Cell Dev Biol       Date:  2018-05       Impact factor: 7.727

10.  Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Authors:  Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.